4-AcO-MiPT

4-AcO-MiPT
Clinical data
Other names4-Acetoxy-N-methyl-N-isopropyltryptamine; Mipracetin
Identifiers
  • 3-{2-[methyl(propan-2-yl)amino]ethyl}-1H-indol-4-yl acetate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H22N2O2
Molar mass274.364 g·mol−1
3D model (JSmol)
  • CC(N(CCC1=CNC2=C1C(OC(C)=O)=CC=C2)C)C
  • InChI=1S/C16H22N2O2/c1-11(2)18(4)9-8-13-10-17-14-6-5-7-15(16(13)14)20-12(3)19/h5-7,10-11,17H,8-9H2,1-4H3 checkY
  • Key:CIDMXLOVFPIHDS-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

4-AcO-MiPT, also known as 4-acetoxy-N-methyl-N-isopropyltryptamine or as mipracetin, is a psychedelic tryptamine. It is closely related to 4-AcO-DMT and methylisopropyltryptamine (MiPT).

There is very little information on the human pharmacology or toxicity of 4-AcO-MiPT, although analytical methods have been developed for its detection.[1][2]

Use and effects

See also: 4-HO-MiPT § Use and effects

Interactions

See also: Psychedelic drug § Interactions, and Trip killer § Serotonergic psychedelic antidotes

Chemistry

Analogues of 4-AcO-MiPT include methylisopropyltryptamine (MiPT), 4-HO-MiPT (miprocin), 5-MeO-MiPT, 4-AcO-DMT (psilacetin), 4-AcO-MET (metacetin), 4-AcO-MPT, 4-AcO-MALT, and 4-AcO-DiPT (ipracetin), among others.

Society and culture

Canada

4-AcO-MiPT is not a controlled substance in Canada as of 2025.[3]

Sweden

Sveriges riksdags health ministry Statens folkhälsoinstitut classified 4-AcO-MiPT as "health hazard" under the act Lagen om förbud mot vissa hälsofarliga varor (translated Act on the Prohibition of Certain Goods Dangerous to Health) as of Nov 1, 2005, in their regulation SFS 2005:733 listed as 4-acetoxi-N,N-metylisopropyltryptamin (4-AcO-MIPT), making it illegal to sell or possess.[4]

United States

4-AcO-MiPT is not an explicitly controlled substance in the United States.[5] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

See also

References

  1. ^ Takahashi M, Nagashima M, Suzuki J, Seto T, Yasuda I, Yoshida T (February 2009). "Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography-mass spectrometry". Talanta. 77 (4): 1245–1272. doi:10.1016/j.talanta.2008.07.062. PMID 19084633.
  2. ^ Noorizadeh H, Farmany A, Noorizadeh M (20 September 2011). "Application of GA–KPLS and L–M ANN calculations for the prediction of the capacity factor of hazardous psychoactive designer drugs". Medicinal Chemistry Research. 21 (9): 2680–2688. doi:10.1007/s00044-011-9794-y. S2CID 16413083.
  3. ^ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
  4. ^ "Förordning om ändring i förordningen (1999:58) om förbud mot vissa hälsofarliga varor" (PDF) (in Swedish). 6 October 2005. Archived from the original (PDF) on 26 June 2021.
  5. ^ Orange Book: List of Controlled Substances and Regulated Chemicals (January 2026) (PDF), United States: U.S. Department of Justice: Drug Enforcement Administration (DEA): Diversion Control Division, January 2026
allikas: http://en.wikipedia.org/wiki/4-AcO-MiPT